Bharat Bitoech International Ltd. stated on Monday that there will be an increase in the number of clinical trials for its COVID-19 vaccine ‘Covaxin’. The company will be only allowing participation of 26,000 volunteers at 25 different trials sites from all over India in next few months.
26,000 volunteers participating for phase 3 trials for Covaxin vaccine
